Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

De Novo Post-Diagnosis Aspirin Use and Mortality in Women with Stage I–III Breast Cancer

Cancer Epidemiol Biomarkers Prev (2015) 24 (6): 898–904.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Influence of postdiagnostic aspirin use on clinical outcomes of women with breast cancer: a meta-analysis
  • Chuanfeng Wu
  • Minmin Hu
  • Shuangling Zhang
  • Jian Zhang
  • Liqing Shen
  • Xueqing Shen
Women & Health (2024) 64 (2): 94.
Low-dose acetylsalicylic acid reduces local inflammation and tissue perfusion in dense breast tissue in postmenopausal women
  • Peter Lundberg
  • Annelie Abrahamsson
  • Johan Kihlberg
  • Jens Tellman
  • Ieva Tomkeviciene
  • Anette Karlsson
  • Maria Kristoffersen Wiberg
  • Marcel Warntjes
  • Charlotta Dabrosin
Breast Cancer Research (2024) 26 (1)
Aspirin Use and Survival Among Patients With Breast Cancer: A Systematic Review and Meta-Analysis
  • Adam Baker
  • Christiana Kartsonaki
The Oncologist (2024) 29 (1): e1.
Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
  • L. Lukas Löfling
  • Nathalie C. Støer
  • Bettina Kulle Andreassen
  • Giske Ursin
  • Edoardo Botteri
Breast Cancer Research (2023) 25 (1)
Research on Clinical Effectiveness of Aspirin for Treating Breast Cancer and Cell Protein Biomarkers on Aspirin Treatment in Drug-Resistant Estrogen Receptor-Positive Breast Cancer Cells
  • Junwei Cui
  • Minghua Li
  • Ruifang Pang
  • Yinhua Liu
Oncologie (2022) 24 (4): 743.
Using linked administrative health data for palliative and end of life care research in Ireland: potential and challenges
  • Maria Kelly
  • Katie M O'Brien
  • Ailish Hannigan
HRB Open Research (2021) 4: 17.
Nonsteroidal Anti-Inflammatory Drugs Reduce Second Cancer Risk in Patients With Breast Cancer: A Nationwide Population-Based Propensity Score-Matched Cohort Study in Taiwan
  • Yin-Che Lu
  • Pin-Tzu Chen
  • Mei-Chen Lin
  • Che-Chen Lin
  • Shi-Heng Wang
  • Yi-Jiun Pan
Frontiers in Oncology (2021) 11
Effect of aspirin use on survival benefits of breast cancer patients
  • Jiamin Liu
  • Fengxian Zheng
  • Meng Yang
  • Xiaoyong Wu
  • Aimin Liu
Medicine (2021) 100 (33): e26870.
Using administrative health data for palliative and end of life care research in Ireland: potential and challenges
  • Maria Kelly
  • Katie M O'Brien
  • Ailish Hannigan
HRB Open Research (2021) 4: 17.
A novel calibration framework for survival analysis when a binary covariate is measured at sparse time points
  • Daniel Nevo
  • Tsuyoshi Hamada
  • Shuji Ogino
  • Molin Wang
Biostatistics (2020) 21 (2): e148.
No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study
  • Gabriella Frisk
  • Sara Ekberg
  • Elisabet Lidbrink
  • Sandra Eloranta
  • Malin Sund
  • Irma Fredriksson
  • Mats Lambe
  • Karin E. Smedby
Breast Cancer Research (2018) 20 (1)
Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?
  • Peter C. Elwood
  • Janet E. Pickering
  • Gareth Morgan
  • Julieta Galante
  • Alison L. Weightman
  • Delyth Morris
  • Marcus Longley
  • Malcolm Mason
  • Richard Adams
  • Sunil Dolwani
  • John Chia W. K.
  • Angel Lanas
  • Daotai Nie
PLOS ONE (2018) 13 (9): e0203957.
Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database
  • Deirdre Cronin-Fenton
  • Timothy L. Lash
  • Thomas P. Ahern
  • Per Damkier
  • Peer Christiansen
  • Bent Ejlertsen
  • Henrik T. Sørensen
Acta Oncologica (2018) 57 (1): 120.
De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival
  • J. M. Madden
  • L. Murphy
  • L. Zgaga
  • K. Bennett
Breast Cancer Research and Treatment (2018) 172 (1): 179.
The potential contribution of dietary factors to breast cancer prevention
  • Niva Shapira
European Journal of Cancer Prevention (2017) 26 (5): 385.
Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study
  • Úna C. Mc Menamin
  • Chris R. Cardwell
  • Carmel M. Hughes
  • Liam J. Murray
Cancer Epidemiology (2017) 47: 20.
Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence
  • Deirdre P. Cronin-Fenton
  • Uffe Heide-Jørgensen
  • Thomas P. Ahern
  • Timothy L. Lash
  • Peer Christiansen
  • Bent Ejlertsen
  • Henrik T. Sørensen
Epidemiology (2016) 27 (4): 586.
Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?
  • M. A. Altinoz
  • N. E. Tunalı
Clinical and Translational Oncology (2016) 18 (1): 9.
Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
  • Marie C. Bradley
  • Amanda Black
  • Andrew N. Freedman
  • Thomas I. Barron
Cancer (2016) 122 (13): 2067.
Do postoperative NSAIDs improve breast cancer outcomes? A Best Evidence Topic
  • Liam Sutton
  • Emma McGlone
  • Kelly Lambert
International Journal of Surgery (2016) 28: 173.
Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies
  • Peter C. Elwood
  • Gareth Morgan
  • Janet E. Pickering
  • Julieta Galante
  • Alison L. Weightman
  • Delyth Morris
  • Mark Kelson
  • Sunil Dolwani
  • Raghib Ali
PLOS ONE (2016) 11 (4): e0152402.
  • Online ISSN 1538-7755
  • Print ISSN 1055-9965

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept